Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
BioAgilytix Labs (BioAgilytix), a leading contract research organization supporting pharmaceutical and biotech partners in all phases of drug development, announced the appointment of Dr. Linda Robbie as Chief Operating Officer.
read more
Thursday, August 18, 2022
Valneva announced that the U.S. Department of Defense (DoD) decided not to exercise the second option year of the contract to supply Valneva’s Japanese encephalitis (JE) vaccine IXIARO®.
read more
Wednesday, August 17, 2022
PharmaLex Group will merge with the Finnish consulting company, DRA Consulting. DRA Consulting becomes part of the broader PharmaLex Nordic region post-merger.
read more
Wednesday, August 17, 2022
Emery Pharma has expanded its lab. The extension of its new laboratory is streamlined to support research and development of large molecule drugs including, biologics, antibody-drug conjugates, biosimilars and others.
read more
Wednesday, August 17, 2022
American Regent acquired HBT Labs. HBT Labs has a pipeline of generic and 505(b)(2) pharmaceutical products that target various treatment indications including cancer and Central Nervous System (CNS) disorders.
read more
Wednesday, August 17, 2022
ProBioGen closed a Master Service Agreement with NextPoint and initiated development and GMP manufacturing of their lead antibody candidate.
read more
Orientation Marketing, a pharmaceutical and life science marketing agency, opened a new office in Espoo, Finland to serve its growing client base in the Nordic and EU regions.
read more
Gerresheimer announced investments to rapidly expand manufacturing, supply and logistics capacity for glass vials in the U.S. The project will be supported by the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of ...
read more
ChargePoint Technology designated Jonathan Bardsley as Global Applications and Solutions Engineering Manager. Jonathan will lead the A&SE (Applications and Solutions Engineering) department, supporting the sales and commercial team in improving the ...
read more
BioIVT, a leading provider of biospecimens, research models and drug and diagnostic development services, acquired Cypex, a renowned manufacturer of recombinant xenobiotic metabolizing enzymes, based in Dundee, Scotland.
read more
Charles River Laboratories, International received regulatory approval, in the form of Good Manufacturing Practice (GMP) certification, to commercially produce allogeneic cell therapy drug products to distribute in Europe, from the European Medicines...
read more
On July 18, 2022, Neil Jones joined Aenova as the new Chief Commercial Officer (CCO) of Aenova Group.
read more
Azenta entered an agreement to acquire B Medical Systems S.á r.l and its subsidiaries ("B Medical"). B Medical is a provider of temperature-controlled storage and transportation solutions globally.
read more
Aptar Pharma acquired worldwide rights to Pharmaxis’ proprietary Orbital™ inhaler, a unique device that can deliver high payload dry powder to the lungs.
read more
Societal CDMO has been awarded CDMO service contracts from three new customers. The agreements include clinical trial services, analytical method and formulation development, and cGMP manufacturing.
read more